Are you fascinated by the way epigenetic gene regulation instructs cell and tissue performance, and how epigenetic aberrations are associated with ageing and disease development? Then the position as Postdoctoral Researcher in epigenetic editing using the CRISPR/Cas platform to study epigenetic reprogramming in (breast cancer) cell lines might suit you and we would be happy to discuss this with you.
With the Epi-Guide-Edit consortium funded by the
NWO Key Technology call we aim to develop and apply the rules and tools for durable epigenetic editing as a key technology across different applications including health, medical and agricultural implementation.
This position is embedded in the group of the program coordinator, Prof. dr. Pernette Verschure,
Swammerdam Institute for Life Sciences and the Dept. of Medical Biochemistry, Amsterdam University Medical Centers (AUMC), University of Amsterdam (UvA), NL. We study epigenetic dynamics, to understand how cell-to-cell variability in epigenetics and transcription timing control cell responsiveness. We have ample experience in the single cell advanced, super resolution quantitative microscopy, epigenetic engineering tools, epigenetic biochemical genome-wide read-outs and computational analysis.
What are you going to do?You will play a central role in predicting which genes respond to induced epigenetic changes. You will apply state-of-the-art in silico tools to identify from single cell resolution pooled epigenetic CRISPR/dCas screens the ground rules of sustained changes in gene functioning with a hit-and-run epigenetic editing approach.
For data analysis and simulation you will work closely together with Dr. Perry Moerland, Bioinformatics Lab, Dept. of Epidemiology and Data Science, AUMC, UvA, NL and Dr. Remco Loos, Informatics & Predictive Sciences, Bristol Myers Squibb, Spain.
Tasks and responsibilities
- assist in producing the experimental data;
- performing analysis of (single cell) epigenomic, transcriptomic and CROP-seq data;
- create data analysis tools to predict the rules for persistent epigenetic editing;
- decipher the influence of transcriptional bursting on permissiveness of epigenetic editing by transient transcriptome-sequencing and
single molecule RNA-FISH;
- engage and collaborate with the various (commercial) stakeholders in the Epi-Guide-Edit consortium.